[R4W4]
General Information
DRACP ID DRACP03596
Peptide Name [R4W4]
Sequence RRRRWWWW
Sequence Length 8
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C68H90N24O9
Absent amino acids ACDEFGHIKLMNPQSTVY
Common amino acids RW
Mass 151264
Pl 12.98
Basic residues 4
Acidic residues 0
Hydrophobic residues 4
Net charge 4
Boman Index -5036
Hydrophobicity -270
Aliphatic Index 0
Half Life
Mammalian: 2.8 hour
Yeast: 10 min
E.coli: 2 min
Extinction Coefficient cystines 22000
Absorbance 280nm 3142.86
Polar residues 0
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 36442155
Title Membrane-Active Cyclic Amphiphilic Peptides: Broad-Spectrum Antibacterial Activity Alone and in Combination with Antibiotics
Doi Not available
Year 2022
Literature 2
Pubmed ID 30360400
Title Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents
Doi Not available
Year 2018
Literature 3
Pubmed ID 28594345
Title Synthesis and Evaluation of Antimicrobial Activity of [R4W4K]-Levofloxacin and [R4W4K]-Levofloxacin-Q Conjugates
Doi Not available
Year 2017
Literature 4
Pubmed ID 25157458
Title Antibacterial activities of amphiphilic cyclic cell-penetrating peptides against multidrug-resistant pathogens
Doi Not available
Year 2014
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID 8109